Non-invasive cortical stimulation for drug-resistant pain.
Luis Garcia-LarreaPublished in: Current opinion in supportive and palliative care (2023)
Both rTMS and tDCS act preferentially upon abnormal hyperexcitable states of pain, rather than acute or experimental pain. For both techniques, M1 appears to be the best target for chronic pain relief, and repeated sessions over relatively long periods of time may be required to obtain clinically significant benefits. Patients responsive to tDCS may differ from those improved by rTMS.
Keyphrases
- chronic pain
- drug resistant
- pain management
- multidrug resistant
- end stage renal disease
- transcranial magnetic stimulation
- acinetobacter baumannii
- neuropathic pain
- transcranial direct current stimulation
- newly diagnosed
- ejection fraction
- chronic kidney disease
- intensive care unit
- liver failure
- pseudomonas aeruginosa
- high frequency
- respiratory failure
- spinal cord
- hepatitis b virus
- aortic dissection
- extracorporeal membrane oxygenation
- cancer therapy